Hims & Hers Super Bowl Ad Faces Scrutiny Over Weight-Loss Claims

The telehealth company aired a controversial ad during the Super Bowl, drawing criticism from lawmakers and a trade group over safety disclosures.

Hims & Hers aired a 60-second Super Bowl ad highlighting obesity as a major health crisis and promoting its weight-loss products.
The ad criticized the U.S. healthcare system, stating it perpetuates poor health while offering weight-loss medication as a solution.
Critics, including two U.S. Senators and a pharmaceutical trade group, argued the ad omitted key safety and side effect information for the featured medication.
The FDA received formal letters urging it to take action against the ad, though it aired unaltered during the Super Bowl's third quarter.
The controversy adds to recent scrutiny of the company, including backlash over a CEO donation to former President Trump's inauguration committee.